Court Place Advisors LLC Sells 13,595 Shares of CVS Health Co. (NYSE:CVS)

Court Place Advisors LLC reduced its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 29.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,105 shares of the pharmacy operator's stock after selling 13,595 shares during the quarter. Court Place Advisors LLC's holdings in CVS Health were worth $1,441,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of CVS. State Street Corp lifted its holdings in CVS Health by 3.6% in the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock valued at $3,554,475,000 after buying an additional 1,989,066 shares during the period. Geode Capital Management LLC boosted its position in shares of CVS Health by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock worth $1,651,997,000 after purchasing an additional 461,569 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of CVS Health by 1.5% during the third quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock worth $825,948,000 after purchasing an additional 198,920 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in CVS Health by 2.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock valued at $767,681,000 after purchasing an additional 304,386 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC lifted its stake in CVS Health by 34.8% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock valued at $748,085,000 after buying an additional 3,071,613 shares during the period. Institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CVS shares. TD Cowen upped their price target on CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, November 25th. Wells Fargo & Company raised CVS Health from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Barclays lowered their price target on CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a report on Thursday, November 7th. StockNews.com lowered shares of CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday, November 14th. Finally, Piper Sandler dropped their price objective on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a report on Monday, November 25th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $68.12.

CVS Health Stock Performance

NYSE:CVS traded up $1.25 during mid-day trading on Tuesday, hitting $57.45. The stock had a trading volume of 14,018,429 shares, compared to its average volume of 13,772,261. The company's 50 day simple moving average is $51.24 and its 200 day simple moving average is $56.19. The stock has a market cap of $72.29 billion, a price-to-earnings ratio of 14.58, a PEG ratio of 0.80 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the previous year, the company posted $2.21 EPS. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities research analysts forecast that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.63%. CVS Health's dividend payout ratio (DPR) is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.